Kymera Therapeutics's total assets for Q4 2024 were $978.03M, a decrease of -5.49% from the previous quarter. KYMR total liabilities were $142.42M for the fiscal quarter, a 0.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.